Contrasting Conversion Labs (CVLBD) & The Competition

Conversion Labs (OTCMKTS:CVLBDGet Rating) is one of 30 public companies in the “Miscellaneous Manufacturing Industries” industry, but how does it compare to its competitors? We will compare Conversion Labs to related companies based on the strength of its institutional ownership, earnings, dividends, analyst recommendations, valuation, risk and profitability.

Earnings & Valuation

This table compares Conversion Labs and its competitors top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Conversion Labs $12.47 million -$3.14 million -2.60
Conversion Labs Competitors $1.70 billion $157.67 million 6.61

Conversion Labs’ competitors have higher revenue and earnings than Conversion Labs. Conversion Labs is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

Conversion Labs has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500. Comparatively, Conversion Labs’ competitors have a beta of 0.25, indicating that their average stock price is 75% less volatile than the S&P 500.

Insider & Institutional Ownership

0.3% of Conversion Labs shares are held by institutional investors. Comparatively, 31.1% of shares of all “Miscellaneous Manufacturing Industries” companies are held by institutional investors. 41.9% of Conversion Labs shares are held by company insiders. Comparatively, 19.3% of shares of all “Miscellaneous Manufacturing Industries” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.


This table compares Conversion Labs and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Conversion Labs -35.92% N/A -260.09%
Conversion Labs Competitors -154.92% -9.03% -11.86%

Analyst Recommendations

This is a summary of current ratings and recommmendations for Conversion Labs and its competitors, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Conversion Labs 0 0 0 0 N/A
Conversion Labs Competitors 60 170 422 12 2.58

As a group, “Miscellaneous Manufacturing Industries” companies have a potential upside of 1.87%. Given Conversion Labs’ competitors higher possible upside, analysts plainly believe Conversion Labs has less favorable growth aspects than its competitors.


Conversion Labs competitors beat Conversion Labs on 6 of the 10 factors compared.

About Conversion Labs

(Get Rating)

Conversion Labs, Inc. engages in the manufacturing, distribution, and sale of natural immune support products containing proprietary yeast beta glucans. Its products are oral intake tablets and topical creams, and gels for skin application. It operates through the Finished Cosmetic Products and Nutraceutical and Cosmetic Additives segments. The company was founded in 1987 and is headquartered in New York, NY.

Receive News & Ratings for Conversion Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Conversion Labs and related companies with's FREE daily email newsletter.